Hims & Hers Health insider plans small August sale after $4.3M disposals

Rhea-AI Filing Summary

Hims & Hers Health, Inc. (HIMS) – Form 144 filing discloses an insider’s intention to sell 250 Class A shares (estimated market value $16,110) on or after 1 Aug 2025 through Fidelity Brokerage on the NYSE. The notice also details recent insider activity: over the past three months the same individual, Michael Y. Chi, has already sold 69,802 Class A shares for gross proceeds of ≈$4.27 million. Outstanding Class A shares total 215.45 million, so the planned sale represents a negligible 0.0001% of shares outstanding, while the cumulative three-month sales equal roughly 0.03%.

The signer affirms he is unaware of any undisclosed material adverse information and, if relying on Rule 10b5-1, that a compliant trading plan exists. No other financial metrics, guidance, or operational updates are provided; the filing is strictly a procedural notice under Rule 144.

Positive

• Sale size is de minimis: 250 shares represent only 0.0001% of the 215.45 m shares outstanding.
• Compliance affirmation: Insider certifies no undisclosed material adverse information, indicating adherence to Rule 144 and governance best practices.

Negative

• Ongoing insider selling: 69,802 shares (~$4.27 m) liquidated over the last three months could dampen investor sentiment.
• Signal risk: Repeated disposals may be interpreted as reduced insider confidence despite immaterial absolute size.

Insights

Securities Analyst

TL;DR: Small additional sale; pattern of insider disposals ~0.03% of float, sentiment slightly negative but immaterial to fundamentals.

The Form 144 signals another minor divestiture by Michael Y. Chi. Although the current 250-share lot is trivial, the aggregate 69.8 k shares sold since June generated ~$4.3 m. Relative to the 215 m share float, this activity is immaterial and unlikely to affect liquidity or ownership structure. Still, repeated insider selling can pressure sentiment, particularly for growth names where perception of executive conviction matters. No operational data accompanies the filing, so valuation drivers remain unchanged.

Corporate Governance Expert

TL;DR: Filing satisfies Rule 144 disclosure; insider certifies no undisclosed adverse info — governance risk low.

Rule 144 requires insiders to pre-notify the market of intended sales. The certification that the insider knows of no material non-public negatives—and possible reliance on a 10b5-1 plan—reduces litigation and governance risk. The modest size relative to float suggests no control implications. However, continued sales create optics of reduced insider alignment that investors may monitor.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Class A	Fidelity Brokerage Services LLC 900 Salem Street Smithfield RI 02917	250	16110.00	215453899	08/01/2025	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Class A	08/01/2025	Options Granted 03/01/2023	Issuer			250	08/01/2025	Cash

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Michael Y. Chi 2269 Chestnut Street #523 San Francisco CA 94123	Class A	06/06/2025	5100	285600.00
Michael Y. Chi 2269 Chestnut Street #523 San Francisco CA 94123	Class A	06/10/2025	5400	307800.00
Michael Y. Chi 2269 Chestnut Street #523 San Francisco CA 94123	Class A	06/17/2025	17102	1021844.50
Michael Y. Chi 2269 Chestnut Street #523 San Francisco CA 94123	Class A	07/23/2025	13750	770000.00
Michael Y. Chi 2269 Chestnut Street #523 San Francisco CA 94123	Class A	07/24/2025	2100	120792.00
Michael Y. Chi 2269 Chestnut Street #523 San Francisco CA 94123	Class A	07/31/2025	26350	1765450.00

144: Remarks and Signature

Remarks

Date of Notice

Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

How many HIMS shares does the insider plan to sell under this Form 144?

The filing covers the proposed sale of 250 Class A shares valued at approximately $16,110.

When is the planned sale date for the HIMS shares?

The insider lists an approximate sale date of 1 August 2025.

How much stock has the insider sold in the last three months?

Previous transactions total 69,802 shares for about $4.27 million in gross proceeds.

What percentage of HIMS’s outstanding shares does the planned sale represent?

Just 0.0001% of the 215.45 million shares outstanding.

Does the filing indicate any undisclosed negative information about HIMS?

No. The signer certifies he is unaware of any material adverse information that has not been publicly disclosed.